Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Takeda Pharmaceutical Company Limited
  6. Charts
  7. Technical Analysis
    4502   JP3463000004

TAKEDA PHARMACEUTICAL COMPANY LIMITED

(4502)
  Report
Delayed Japan Exchange  -  02:00 2022-07-06 am EDT
3862.00 JPY   +0.63%
07/01Takeda's Takhzyro Shows 94.8% Reduction in Hereditary Angioedema Attacks in Phase 3 Trial in Children
MT
06/30TAKEDA PHARMACEUTICAL : Phase 3 SPRING study data presented at EAACI
PU
06/30Takeda's TAKHZYRO® (lanadelumab) Demonstrated Positive Results in the Prevention of HAE Attacks in First and Only Open-Label Phase 3 Trial in Children Ages 2 to <12 Years
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 Technical AnalysisHistorical ChartNews ChartSector ChartComparison ChartReversed ChartRelative Strength Chart
Static chartExpert dynamic chartDynamic Chart 
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance3 9304 1694 191
Spread/Res.-1,7%-7,4%-7,9%
Spread/Supp.5,4%9,3%12%
Support3 6653 5353 434
Notations Surperformance© of Takeda Pharmaceutical Company Limited  Help  
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes